Loading chat...
NY A07501
Bill
Status
Introduced
3/28/2025
Primary Sponsor
Edward Braunstein
Click for details
AI Summary
-
Adds tianeptine sodium to Schedule II of controlled substances under New York's Public Health Law section 3306
-
Schedule II classification designates substances with high potential for abuse but accepted medical use with severe restrictions
-
Takes effect 90 days after becoming law
-
Introduced by Assembly Member Braunstein and referred to the Committee on Health
Legislative Description
Adds tianeptine sodium to list of Schedule II of controlled substances.
Last Action
referred to health
1/7/2026
Committee Referrals
Health3/28/2025
Full Bill Text
No bill text available